Global Burden of Disease Study 2019: an opportunity to understand the growing prevalence and impact of hip, knee, hand and other osteoarthritis in Australia.
Global Burden of Disease
disease burden
hand
hip
knee
osteoarthritis
Journal
Internal medicine journal
ISSN: 1445-5994
Titre abrégé: Intern Med J
Pays: Australia
ID NLM: 101092952
Informations de publication
Date de publication:
10 2023
10 2023
Historique:
received:
20
06
2022
accepted:
08
09
2022
medline:
23
10
2023
pubmed:
18
9
2022
entrez:
17
9
2022
Statut:
ppublish
Résumé
Understanding population-level trends in osteoarthritis (OA) is critical for planning health services and disease prevention initiatives. To examine trends in the burden of hip, knee, hand and other OA related conditions in Australia from 1990 to 2019 and consider the OA burden in the context of other common conditions associated with older age. Global Burden of Disease Study 2019 data for Australia on OA prevalence, OA-related years lived with disability (YLDs) and OA-related YLDs attributable to high body mass index (BMI) were sourced for 1990-2019. Age-standardised YLD data for ischaemic heart disease, stroke, dementia, type 2 diabetes and chronic obstructive pulmonary disease were obtained for comparison. Overall, 3.20 million Australians were estimated to have OA in 2019, with substantial growth in the prevalence of hip (+171%), knee (+126%), hand (+110%) and other types of OA (+130%) from 1990 to 2019. Age-standardised prevalence rates reflect the contribution of population ageing. Concomitant growth in OA-related YLDs was also evident; knee OA and hand OA demonstrated the highest disease burden in 2019 (59 684 and 41 893 YLDs respectively). The proportion of knee OA burden attributable to high BMI was 36% in 2019. In 2019, age-standardised YLD rates were higher for OA (313 per 100 000 population) than other common conditions (range: 47 per 100 000 (ischaemic heart disease) to 284 per 100 000 (type 2 diabetes)). OA is an increasingly prevalent, impactful condition with a high non-fatal disease burden relative to other health conditions. Growth in OA populations and OA-related disability underscore the need for enhanced investment in prevention and management.
Sections du résumé
BACKGROUND
Understanding population-level trends in osteoarthritis (OA) is critical for planning health services and disease prevention initiatives.
AIM
To examine trends in the burden of hip, knee, hand and other OA related conditions in Australia from 1990 to 2019 and consider the OA burden in the context of other common conditions associated with older age.
METHODS
Global Burden of Disease Study 2019 data for Australia on OA prevalence, OA-related years lived with disability (YLDs) and OA-related YLDs attributable to high body mass index (BMI) were sourced for 1990-2019. Age-standardised YLD data for ischaemic heart disease, stroke, dementia, type 2 diabetes and chronic obstructive pulmonary disease were obtained for comparison.
RESULTS
Overall, 3.20 million Australians were estimated to have OA in 2019, with substantial growth in the prevalence of hip (+171%), knee (+126%), hand (+110%) and other types of OA (+130%) from 1990 to 2019. Age-standardised prevalence rates reflect the contribution of population ageing. Concomitant growth in OA-related YLDs was also evident; knee OA and hand OA demonstrated the highest disease burden in 2019 (59 684 and 41 893 YLDs respectively). The proportion of knee OA burden attributable to high BMI was 36% in 2019. In 2019, age-standardised YLD rates were higher for OA (313 per 100 000 population) than other common conditions (range: 47 per 100 000 (ischaemic heart disease) to 284 per 100 000 (type 2 diabetes)).
CONCLUSIONS
OA is an increasingly prevalent, impactful condition with a high non-fatal disease burden relative to other health conditions. Growth in OA populations and OA-related disability underscore the need for enhanced investment in prevention and management.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1875-1882Subventions
Organisme : Monash University
ID : N/A
Organisme : National Health and Medical Research Council
ID : APP1194482
Informations de copyright
© 2022 The Authors. Internal Medicine Journal published by John Wiley & Sons Australia, Ltd on behalf of Royal Australasian College of Physicians.
Références
Arthritis Care Res (Hoboken). 2011 Jun;63(6):788-99
pubmed: 21538946
Med J Aust. 2016 Feb 1;204(2):47
pubmed: 26821091
Bone. 2006 Nov;39(5):1149-1155
pubmed: 16844440
Chiropr Man Therap. 2022 May 3;30(1):22
pubmed: 35505334
J Orthop Sports Phys Ther. 2017 Feb;47(2):67-79
pubmed: 28142365
Osteoarthritis Cartilage. 2015 Jul;23(7):1138-43
pubmed: 25749009
BMC Musculoskelet Disord. 2012 Dec 20;13:254
pubmed: 23253742
Pharmacoeconomics. 2021 Mar;39(3):271-273
pubmed: 33428173
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
Osteoarthritis Cartilage. 2017 Apr;25(4):455-461
pubmed: 27856293
Arthritis Care Res (Hoboken). 2018 Jun;70(6):877-883
pubmed: 28898565
Osteoarthritis Cartilage. 2022 Aug;30(8):1070-1078
pubmed: 35598766
Int J Obes (Lond). 2021 Jun;45(6):1249-1258
pubmed: 33658682
J Orthop Sports Phys Ther. 2018 Jun;48(6):439-447
pubmed: 29669488
Arthritis Care Res (Hoboken). 2017 Nov;69(11):1659-1667
pubmed: 28152269
BMJ Glob Health. 2021 May;6(5):
pubmed: 34001521
Aging Clin Exp Res. 2005 Aug;17(4):255-63
pubmed: 16285189
Ann Rheum Dis. 2014 Jul;73(7):1323-30
pubmed: 24553908